MDI Biological Laboratory
Disease models and transgenic biosensors
this is a placeholder graphic
High throughput screening and advanced imaging
this is a placeholder graphic
Early assessment of efficacy and toxicity in whole organisms
this is a placeholder graphic

MDI Bioscience

Discovering new medicines is a complex and risky endeavor. Only 1 in 5,000 new discoveries will become an approved drug for addressing human disease. MDI Bioscience develops innovative disease models to accelerate the transformation of research discoveries into human therapies.

About MDI Bioscience

MDI Bioscience harnesses the cutting-edge expertise of MDI Biological Laboratory’s researchers to drive inventive solutions to real-world health challenges like diabetes, inflammation, skin pigmentation disorders, and exposure to PFAS “forever” chemicals.

Using a unique array of models for human health, including transgenic zebrafish, lab-grown organoids and advanced computational systems, MDI Bioscience is creating new ways to bridge the gap between lab bench and clinical trial.

Instead of relying solely on costly and time-consuming mouse or primate studies, we're building precise biological models that can quickly show how different compounds might help or harm our bodies. We take a collaborative, entrepreneurial approach to speed up medical research, find promising new treatments, and do it all in a way that's more efficient and cost-effective.

MDI Bioscience focuses on the early, high-risk phase of drug discovery that the pharmaceutical industry rarely backs—where ideas may be unconventional, but full of potential.